---
title: "SFPM: The application for the registration and listing license of Fusidic Acid Cream has been accepted"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263959623.md"
description: "SFPM's wholly-owned subsidiary Harbin SFPM recently received the \"Acceptance Notice\" from the National Medical Products Administration regarding the application for the registration and marketing authorization of fusidic acid cream. This medication is primarily used to treat skin infections caused by various bacteria, with indications including pustules, boils, and carbuncles, suitable for facial and scalp infections"
datetime: "2025-11-03T07:46:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263959623.md)
  - [en](https://longbridge.com/en/news/263959623.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263959623.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263959623.md) | [English](https://longbridge.com/en/news/263959623.md)


# SFPM: The application for the registration and listing license of Fusidic Acid Cream has been accepted

According to the Zhitong Finance APP, SFPM (002737.SZ) announced that its wholly-owned subsidiary Harbin SFPM recently received the "Acceptance Notice" from the National Medical Products Administration regarding the application for the registration and marketing authorization of fusidic acid cream. Fusidic acid cream is indicated for skin infections caused by Staphylococcus, Streptococcus, Propionibacterium acnes, Corynebacterium, and other bacteria sensitive to fusidic acid. The main indications include: pustules, boils, carbuncles, paronychia, wound infections, folliculitis, hidradenitis, erythrasma, and common acne. This product is suitable for infections in areas such as the face and head without affecting appearance

### 相關股票

- [SFPM (002737.CN)](https://longbridge.com/zh-HK/quote/002737.CN.md)

## 相關資訊與研究

- [FDA investigating illnesses linked to raw cheddar cheese from California farm](https://longbridge.com/zh-HK/news/279302901.md)
- [“One Battle After Another” Wins USA TODAY’s Movie Meter Competition | TDAY Stock News](https://longbridge.com/zh-HK/news/279245283.md)
- [WHO directs antibiotic development to priority pathogens](https://longbridge.com/zh-HK/news/279045396.md)
- [Appeal trial opens for France's Sarkozy over alleged Libyan funding](https://longbridge.com/zh-HK/news/279275237.md)
- [08:24 ETZentiva vydává Zprávu o udržitelnosti za rok 2025, čímž posiluje svůj závazek vůči lidem, partnerům a planetě.](https://longbridge.com/zh-HK/news/279431011.md)